Your browser doesn't support javascript.
loading
Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study.
Bilger, Geoffroy; Girard, Nicolas; Doubre, Hélène; Levra, Matteo Giaj; Giroux-Leprieur, Etienne; Giraud, Frederique; Decroisette, Chantal; Carton, Matthieu; Massiani, Marie Ange.
Affiliation
  • Bilger G; Medical Oncology, Institut Curie, Saint Cloud, France. bilger.geoffroy@gmail.com.
  • Girard N; Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.
  • Doubre H; Thoracic Oncology, Hopital Foch, Suresnes, France.
  • Levra MG; Thoracic Oncology Unit, CHU Grenobles Alpes, La Tronche, France.
  • Giroux-Leprieur E; Respiratory Diseases and Thoracic Oncology, Hopital Ambroise Pare, Boulogne Billancourt, France.
  • Giraud F; Pneumo-Oncology, Hôpital Cochin, Paris, France.
  • Decroisette C; Respiratory Diseases and Thoracic Oncology, Le Centre Hospitalier Annecy Genevois, Metz-Tessy, France.
  • Carton M; Unit of Biometry, Institut Curie, DRCI, PSL Research University, Paris, France.
  • Massiani MA; Medical Oncology, Institut Curie, Saint Cloud, France.
Cancer Immunol Immunother ; 71(7): 1719-1731, 2022 Jul.
Article in En | MEDLINE | ID: mdl-34821950
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2022 Type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2022 Type: Article Affiliation country: France